175 related articles for article (PubMed ID: 27881164)
1. Administration of anti-receptor activator of nuclear factor-kappa B ligand (RANKL) antibody for the treatment of osteoporosis was associated with amelioration of hepatitis in a female patient with growth hormone deficiency: a case report.
Takeno A; Yamamoto M; Notsu M; Sugimoto T
BMC Endocr Disord; 2016 Nov; 16(1):66. PubMed ID: 27881164
[TBL] [Abstract][Full Text] [Related]
2. Long-term effects of growth hormone replacement therapy on liver function in adult patients with growth hormone deficiency.
Matsumoto R; Fukuoka H; Iguchi G; Nishizawa H; Bando H; Suda K; Takahashi M; Takahashi Y
Growth Horm IGF Res; 2014 Oct; 24(5):174-9. PubMed ID: 25116471
[TBL] [Abstract][Full Text] [Related]
3. Resolution of non-alcoholic steatohepatitis after growth hormone replacement in a pediatric liver transplant patient with panhypopituitarism.
Gilliland T; Dufour S; Shulman GI; Petersen KF; Emre SH
Pediatr Transplant; 2016 Dec; 20(8):1157-1163. PubMed ID: 27762491
[TBL] [Abstract][Full Text] [Related]
4. [Updates of denosumab, anti-RANKL antibody for osteoporosis].
Tokuyama N; Tanaka S
Clin Calcium; 2014 Jan; 24(1):85-91. PubMed ID: 24369284
[TBL] [Abstract][Full Text] [Related]
5. Role of osteoprotegerin/receptor activator of nuclear factor kappa B/receptor activator of nuclear factor kappa B ligand axis in nonalcoholic fatty liver disease.
Pacifico L; Andreoli GM; D'Avanzo M; De Mitri D; Pierimarchi P
World J Gastroenterol; 2018 May; 24(19):2073-2082. PubMed ID: 29785076
[TBL] [Abstract][Full Text] [Related]
6. Enhanced immunoprotective effects by anti-IL-17 antibody translates to improved skeletal parameters under estrogen deficiency compared with anti-RANKL and anti-TNF-α antibodies.
Tyagi AM; Mansoori MN; Srivastava K; Khan MP; Kureel J; Dixit M; Shukla P; Trivedi R; Chattopadhyay N; Singh D
J Bone Miner Res; 2014 Sep; 29(9):1981-92. PubMed ID: 24677326
[TBL] [Abstract][Full Text] [Related]
7. [Anti-RANKL antibody].
Omiya T; Tanaka S
Nihon Rinsho; 2015 Oct; 73(10):1690-5. PubMed ID: 26529931
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone reverses nonalcoholic steatohepatitis in a patient with adult growth hormone deficiency.
Takahashi Y; Iida K; Takahashi K; Yoshioka S; Fukuoka H; Takeno R; Imanaka M; Nishizawa H; Takahashi M; Seo Y; Hayashi Y; Kondo T; Okimura Y; Kaji H; Kitazawa R; Kitazawa S; Chihara K
Gastroenterology; 2007 Mar; 132(3):938-43. PubMed ID: 17324404
[TBL] [Abstract][Full Text] [Related]
9. Long-term survival with growth hormone replacement after liver transplantation of pediatric nonalcoholic steatohepatitis complicating acquired hypopituitarism.
Fujio A; Kawagishi N; Echizenya T; Tokodai K; Nakanishi C; Miyagi S; Sato K; Fujimori K; Ohuchi N
Tohoku J Exp Med; 2015 Jan; 235(1):61-7. PubMed ID: 25744617
[TBL] [Abstract][Full Text] [Related]
10. Decoding cell death signals in liver inflammation.
Brenner C; Galluzzi L; Kepp O; Kroemer G
J Hepatol; 2013 Sep; 59(3):583-94. PubMed ID: 23567086
[TBL] [Abstract][Full Text] [Related]
11. A Probable Case of Burn-out NASH Caused by Panhypopituitarism Secondary to Craniopharyngioma.
Terawaki Y; Murase K; Motonaga R; Tanabe M; Nomiyama T; Shakado S; Mizoguchi M; Sakisaka S; Yanase T
Fukuoka Igaku Zasshi; 2016 Mar; 107(3):53-61. PubMed ID: 29115108
[TBL] [Abstract][Full Text] [Related]
12. Association of nonalcoholic fatty liver disease and growth hormone deficiency: a systematic review and meta-analysis.
Kong T; Gu Y; Sun L; Zhou R; Li J; Shi J
Endocr J; 2023 Oct; 70(10):959-967. PubMed ID: 37468264
[TBL] [Abstract][Full Text] [Related]
13. Serum osteoprotegerin and RANKL levels in chronic alcoholic liver disease.
García-Valdecasas-Campelo E; González-Reimers E; Santolaria-Fernández F; De la Vega-Prieto MJ; Milena-Abril A; Sánchez-Pérez MJ; Martínez-Riera A; Gómez-Rodríguez Mde L
Alcohol Alcohol; 2006; 41(3):261-6. PubMed ID: 16476762
[TBL] [Abstract][Full Text] [Related]
14. A case of minimal change disease after the administration of anti receptor activator of nuclear factor kappa B ligand (RANKL) monoclonal antibody: a case report.
Horikoshi K; Sakai N; Yamamoto N; Ogura H; Sato K; Miyagawa T; Kitajima S; Toyama T; Hara A; Iwata Y; Shimizu M; Furuichi K; Wada T
BMC Nephrol; 2020 Sep; 21(1):416. PubMed ID: 32993539
[TBL] [Abstract][Full Text] [Related]
15. Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis.
Afonso MB; Rodrigues PM; Carvalho T; Caridade M; Borralho P; Cortez-Pinto H; Castro RE; Rodrigues CM
Clin Sci (Lond); 2015 Oct; 129(8):721-39. PubMed ID: 26201023
[TBL] [Abstract][Full Text] [Related]
16. S100A8 Production in CXCR2-Expressing CD11b+Gr-1high Cells Aggravates Hepatitis in Mice Fed a High-Fat and High-Cholesterol Diet.
Mukai K; Miyagi T; Nishio K; Yokoyama Y; Yoshioka T; Saito Y; Tanaka S; Shigekawa M; Nawa T; Hikita H; Sakamori R; Yoshihara H; Imai Y; Hiramatsu N; Tatsumi T; Takehara T
J Immunol; 2016 Jan; 196(1):395-406. PubMed ID: 26608915
[TBL] [Abstract][Full Text] [Related]
17. Changes in serum receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and interleukin-6 levels in patients with glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1-34).
Buxton EC; Yao W; Lane NE
J Clin Endocrinol Metab; 2004 Jul; 89(7):3332-6. PubMed ID: 15240611
[TBL] [Abstract][Full Text] [Related]
18. Fish liver oil and propolis as protective natural products against the effect of the anti-epileptic drug valproate on immunological markers of bone formation in rats.
Elwakkad AS; El Elshamy KA; Sibaii H
Epilepsy Res; 2008 Jul; 80(1):47-56. PubMed ID: 18455911
[TBL] [Abstract][Full Text] [Related]
19. Targeting the RANK/RANKL/OPG signaling pathway: a novel approach in the management of osteoporosis.
Hamdy NA
Curr Opin Investig Drugs; 2007 Apr; 8(4):299-303. PubMed ID: 17458179
[TBL] [Abstract][Full Text] [Related]
20. Interrelationship of circulating matrix metalloproteinase-9, TNF-α, and OPG/RANK/RANKL systems in COPD patients with osteoporosis.
Zhang PF; Pan L; Luo ZY; Zhao HJ; Cai SX
COPD; 2013 Dec; 10(6):650-6. PubMed ID: 23845033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
